Literature DB >> 7530503

The role of the homeobox gene, HOX B7, in human myelomonocytic differentiation.

M C Lill1, J F Fuller, R Herzig, G M Crooks, J C Gasson.   

Abstract

Homeobox genes encode transcription factors known to be important morphogenic regulators during embryogenesis. An increasing body of work implies a role for homeobox genes in both hematopoiesis and oncogenesis. We have analyzed the role of the homeobox gene, HOX B7, in the program of differentiation of the biphenotypic myeloid cell line, HL60. Induction of monocytic differentiation in HL-60 cells by vitamin D3 resulted in rapid expression of HOX B7 mRNA, but stimulation with phorbol ester or dimethyl sulfoxide (DMSO) did not. Constitutive overexpression of HOX B7 in the HL60 cell line inhibited the granulocytic differentiation associated with stimulation with DMSO or retinoic acid, but had no effect on the monocytic differentiation induced by vitamin D3. Normal human monocytes do not constitutively express HOX B7, nor are they able to be induced to do so by stimulation with colony-stimulating factor 1 (CSF-1) and gamma interferon (IFN gamma), or with vitamin D3 and lipopolysaccharide. Human bone marrow (BM) cells were found to express HOX B7 in response to granulocyte-macrophage CSF (GM-CSF) and antisense oligonucleotides directed against HOX B7 inhibited the formation of colonies derived from GM-CSF-stimulated BM. These data suggest a critical role for HOX B7 in myelomonocytic differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530503

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

2.  Inhibition of DLX-7 homeobox gene causes decreased expression of GATA-1 and c-myc genes and apoptosis.

Authors:  T Shimamoto; S Nakamura; J Bollekens; F H Ruddle; K Takeshita
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

3.  Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.

Authors:  Anna M Eiring; Paolo Neviani; Ramasamy Santhanam; Joshua J Oaks; Ji Suk Chang; Mario Notari; William Willis; Carlo Gambacorti-Passerini; Stefano Volinia; Guido Marcucci; Michael A Caligiuri; Gustavo W Leone; Danilo Perrotti
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

4.  Single-channel quantitative multiplex reverse transcriptase-polymerase chain reaction for large numbers of gene products differentiates nondemented from neuropathological Alzheimer's disease.

Authors:  Stavros Therianos; Min Zhu; Eunice Pyun; Paul D Coleman
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

5.  Automatically extracting functionally equivalent proteins from SwissProt.

Authors:  Lisa E M McMillan; Andrew C R Martin
Journal:  BMC Bioinformatics       Date:  2008-10-06       Impact factor: 3.169

6.  Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia.

Authors:  Aparna Raval; Stephan M Tanner; John C Byrd; Elizabeth B Angerman; James D Perko; Shih-Shih Chen; Björn Hackanson; Michael R Grever; David M Lucas; Jennifer J Matkovic; Thomas S Lin; Thomas J Kipps; Fiona Murray; Dennis Weisenburger; Warren Sanger; Jane Lynch; Patrice Watson; Mary Jansen; Yuko Yoshinaga; Richard Rosenquist; Pieter J de Jong; Penny Coggill; Stephan Beck; Henry Lynch; Albert de la Chapelle; Christoph Plass
Journal:  Cell       Date:  2007-06-01       Impact factor: 41.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.